Identification of Mutations Associated With Macozinone-Resistant in Mycobacterium Tuberculosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Identification of Mutations Associated With Macozinone-Resistant in Mycobacterium Tuberculosis

Published:2022-05-26 Issue:7 Volume:79 Page:
ISSN:0343-8651
Container-title:Current Microbiology
language:en
Short-container-title:Curr Microbiol

Author:

Chen Xi,Li Yuanyuan,Wang Bin,Lu Yu^ORCID

Funder

National Major Science and Technology Projects of China

National Natural Science Foundation of China

Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support

Publisher

Springer Science and Business Media LLC

Subject

Applied Microbiology and Biotechnology,General Medicine,Microbiology

Link

https://link.springer.com/content/pdf/10.1007/s00284-022-02881-x.pdf

Reference30 articles.

1. World Health Organization (WHO) 2019 Global Tuberculosis Report World Health Organization Geneva

2. P Brouqui F Quenard M Drancourt 2017 Old antibiotics for emerging multidrug-resistant/extensively drug-resistant tuberculosis (MDR/XDR-TB) Int J Antimicrob Agents 49 554 557 https://doi.org/10.1016/j.ijantimicag.2017.02.008

3. R Diel J Vandeputte G Vries de J Stillo M Wanlin A Nienhaus 2014 Costs of tuberculosis disease in the European Union: a systematic analysis and cost calculation Eur Respir J 43 554 565 https://doi.org/10.1183/09031936.00079413

4. K Dheda JD Limberis E Pietersen J Phelan A Esmail M Lesosky KP Fennelly J Riele Te B Mastrapa EM Streicher T Dolby AM Abdallah F Ben-Rached J Simpson L Smith T Gumbo P Helden van FA Sirgel R McNerney G Theron A Pain TG Clark RM Warren 2017 Outcomes, infectiousness, and transmission dynamics of patients with extensively drug-resistant tuberculosis and home-discharged patients with programmatically incurable tuberculosis: a prospective cohort study Lancet Respir Med 5 269 281

5. A Bahuguna DS Rawat 2020 An overview of new antitubercular drugs, drug candidates, and their targets Med Res Rev 40 263 292 https://doi.org/10.1002/med.21602

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DprE1 and Ddn as promising therapeutic targets in the development of novel anti-tuberculosis nitroaromatic drugs;European Journal of Medicinal Chemistry;2024-08

2. Targeting decaprenylphosphoryl-β-D-ribose 2′-epimerase for Innovative Drug Development Against Mycobacterium Tuberculosis Drug-Resistant Strains;Bioinformatics and Biology Insights;2024-01

3. The evolution of antibiotic resistance is associated with collateral drug phenotypes in Mycobacterium tuberculosis;Nature Communications;2023-03-18

4. Synthesis, structures, reactivity and medicinal chemistry of antitubercular benzothiazinones;Chemical Communications;2023

5. An insight into the discovery, clinical studies, compositions, and patents of macozinone: A drug targeting the DprE1 enzyme of Mycobacterium tuberculosis;Journal of Infection and Public Health;2022-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3